2012
DOI: 10.1016/j.neurobiolaging.2010.08.013
|View full text |Cite
|
Sign up to set email alerts
|

Role of neuroinflammation in hypertension-induced brain amyloid pathology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

3
65
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 87 publications
(68 citation statements)
references
References 27 publications
3
65
0
Order By: Relevance
“…15,25,28 Using transverse aortic constriction and angiotensin II infusion, cerebral amyloid deposition was observed as early as 4 weeks after the insult in both models. 15 They observed an increased permeability of the blood-brain barrier with albumin leakage in the cortex. In several brain areas controlling cognitive functions, such as the cortex, soluble oligomers and intermediate amyloids were recognized.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…15,25,28 Using transverse aortic constriction and angiotensin II infusion, cerebral amyloid deposition was observed as early as 4 weeks after the insult in both models. 15 They observed an increased permeability of the blood-brain barrier with albumin leakage in the cortex. In several brain areas controlling cognitive functions, such as the cortex, soluble oligomers and intermediate amyloids were recognized.…”
Section: Discussionmentioning
confidence: 99%
“…16 For detection of chronotropic activity of various Aβ peptides, Aβ (1)(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14)(15), Aβ (25)(26)(27)(28)(29)(30)(31)(32)(33)(34)(35), Aβ (10-35), Aβ , and Aβ (1-42) obtained from antibodies-online were added to neonatal rat cardiomyocytes at a concentration of 0.1 µmol/L. To show activation of a G-protein-coupled receptor and identify the receptor, β 1 (bisoprolol, 1 µmol/L) and β 2 (ICI 118.551, 0.1 µmol/L) adrenergic receptor antagonist, angiotensin II receptor type 1 (AT 1 ) receptor blocker, 1 µmol/L irbesartan, α 1A -AR blockers, 1 µmol/L prazosin, and 1 µmol/L urapidil were added.…”
Section: Cardiac Contraction Assay Preparation Of Human α 1 -Ar Antimentioning
confidence: 99%
“…Epidemiological studies provide evidence that in addition to the increased prevalence of hypertension in aging, the deleterious cerebrovascular effects of hypertension are also exacerbated in elderly patients, whereas younger subjects appear to be more protected from cerebromicrovascular and neurological damage induced by elevated blood pressure (10,38,54). There is strong evidence showing that in older patients hypertensioninduced microvascular injury not only promotes the development of vascular cognitive impairment (24,29,45) but it also significantly increases the risk (risk ratio ϭ ϳ1.5) for sporadic Alzheimer's disease (25,31), supporting the vascular hypothesis of the disease (11)(12)(13). Although the available human data suggest that advanced age and hypertension have synergistic effects (45), the specific age-related mechanisms through which aging increases the vulnerability of the cerebromicrovasculature to hypertension are not well documented in the literature.…”
mentioning
confidence: 90%
“…37 These findings should be interpreted in the knowledge that such biomarkers may also be increased in patients with more general cardiovascular disease. In general, the functional consequences of neuroinflammation are currently unclear, 43 particularly in relation to CABG surgery and POCD.…”
Section: Hogan Et Al Fixing Hearts and Protecting Minds 163mentioning
confidence: 99%